Celator Pharmaceuticals, Inc.(NASDAQ : CPXX)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.45%||166.93||0.7%||$1253.55m|
|LLY||Eli Lilly & Co.||0.18%||311.43||1.1%||$814.08m|
|BMY||Bristol-Myers Squibb Co.||-0.73%||70.77||1.0%||$778.85m|
|MRK||Merck & Co., Inc.||-0.81%||86.80||0.7%||$691.58m|
|ALNY||Alnylam Pharmaceuticals, Inc.||-0.95%||200.78||8.2%||$207.03m|
|GBT||Global Blood Therapeutics, Inc.||0.03%||67.99||5.4%||$199.71m|
|NVO||Novo Nordisk A/S||-0.40%||97.92||0.1%||$170.11m|
|HZNP||Horizon Therapeutics Plc||0.54%||62.97||5.4%||$156.21m|
|SRPT||Sarepta Therapeutics, Inc.||-2.42%||108.19||12.4%||$128.76m|
Celator Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat cancer. The company focuses on CombiPlex, a drug ratio technology platform that enables to the development of combination therapies. Its products include CPX-1 (Irinotecan HCI-Floxuridine), a treatment for colorectal cancer; and CPX-351 (Cytarabine-Daunorubicin), a treatment for acute myeloid leukemia (AML). Celator Pharmaceuticals, Inc. was formerly known as Celator Technologies, Inc. The company was founded in 2000 and is headquartered in Princeton, New Jersey.